Landmark study shows promising results for autoimmune diseases

OHSU enrolls three patients in RNA cell therapy study

By Erik Robinson June 22, 2023 Portland, Oregon

Downloads

Kylie Swenson, OHSU clinical trial patient

Kylie Swenson, 39, is an OHSU clinical trial participant who lives in Central Point. The clinical trial uses a form of chimeric antigen receptor, or CAR-T, to treat generalized myasthenia gravis, or MG, a debilitating autoimmune neurological disease. (Courtesy of Kylie Swenson)

Kylie Swenson at the beach

Nizar Chahin, M.D., study shows promising results for autoimmune diseases

Nizar Chahin, M.D., assistant professor of neurology in the OHSU School of Medicine and director of neuromuscular treatment for OHSU Health. (OHSU/Christine Torres Hicks)

Nizar Chahin, M.D.

Nizar Chahin, M.D., assistant professor of neurology in the OHSU School of Medicine and director of neuromuscular treatment for OHSU Health. (OHSU/Christine Torres Hicks)